Literature DB >> 2139725

Molecular cloning of the CD3 eta subunit identifies a CD3 zeta-related product in thymus-derived cells.

Y J Jin1, L K Clayton, F D Howard, S Koyasu, M Sieh, R Steinbrich, G E Tarr, E L Reinherz.   

Abstract

The CD3 eta subunit of the T-cell antigen receptor forms a heterodimeric structure with the CD3 zeta subunit in thymus-derived lymphoid cells and is apparently involved in signal transduction through the receptor. Here we report the primary structure of murine CD3 eta as deduced from protein microsequencing and cDNA cloning. The mature protein is divided into three domains: a 9-amino acid extracellular segment, a 21-amino acid transmembrane segment including a negatively charged residue characteristic of CD3 subunits, and a 155-amino acid cytoplasmic tail. The NH2-terminal sequences of CD3 eta and CD3 zeta are identical through amino acid 122 of each mature protein but then diverge in the remainder of their respective COOH-terminal regions, consistent with alternatively spliced products of a common gene. The cytoplasmic domain of CD3 eta is 42 amino acids larger than that of CD3 zeta but lacks one of six potential tyrosine phosphorylation sites as well as a putative nucleotide binding site previously identified in CD3 zeta. These structural features presumably account for the difference between CD3 eta and CD3 zeta function and are consistent with the notion that CD3 eta may be an important component of a T-cell receptor isoform(s) during thymic development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139725      PMCID: PMC53891          DOI: 10.1073/pnas.87.9.3319

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Molecular cloning of the zeta chain of the T cell antigen receptor.

Authors:  A M Weissman; M Baniyash; D Hou; L E Samelson; W H Burgess; R D Klausner
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

2.  A new method for predicting signal sequence cleavage sites.

Authors:  G von Heijne
Journal:  Nucleic Acids Res       Date:  1986-06-11       Impact factor: 16.971

3.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

4.  Predicted nucleotide-binding properties of p21 protein and its cancer-associated variant.

Authors:  R K Wierenga; W G Hol
Journal:  Nature       Date:  1983-04-28       Impact factor: 49.962

Review 5.  The human T-cell receptor.

Authors:  S C Meuer; O Acuto; T Hercend; S F Schlossman; E L Reinherz
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

Review 6.  Phosphate-binding sequences in nucleotide-binding proteins.

Authors:  W Möller; R Amons
Journal:  FEBS Lett       Date:  1985-07-01       Impact factor: 4.124

7.  Activation-driven programmed cell death and T cell receptor zeta eta expression.

Authors:  M Merćep; A M Weissman; S J Frank; R D Klausner; J D Ashwell
Journal:  Science       Date:  1989-12-01       Impact factor: 47.728

8.  Failure to synthesize the T cell CD3-zeta chain: structure and function of a partial T cell receptor complex.

Authors:  J J Sussman; J S Bonifacino; J Lippincott-Schwartz; A M Weissman; T Saito; R D Klausner; J D Ashwell
Journal:  Cell       Date:  1988-01-15       Impact factor: 41.582

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody.

Authors:  K Haskins; R Kubo; J White; M Pigeon; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

View more
  36 in total

1.  CD3 zeta dependence of the CD2 pathway of activation in T lymphocytes and natural killer cells.

Authors:  P Moingeon; J L Lucich; D J McConkey; F Letourneur; B Malissen; J Kochan; H C Chang; H R Rodewald; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

2.  p59fyn tyrosine kinase associates with multiple T-cell receptor subunits through its unique amino-terminal domain.

Authors:  L K Timson Gauen; A N Kong; L E Samelson; A S Shaw
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

Review 3.  Structure and function of the T cell antigen receptor.

Authors:  A Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  T-cell and basophil activation through the cytoplasmic tail of T-cell-receptor zeta family proteins.

Authors:  F Letourneur; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Primary structure and ontogeny of an avian CD3 transcript.

Authors:  A Bernot; C Auffray
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

Review 6.  Mouse chromosome 1.

Authors:  M F Seldin; T H Roderick; B Paigen
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

7.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1990-09-11       Impact factor: 16.971

8.  TCR kappa, a new splicing of the murine TCR zeta gene locus, is modulated by glucocorticoid treatment.

Authors:  L Giunchi; G Nocentini; S Ronchetti; A Bartoli; C Riccardi; G Migliorati
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

9.  A linkage map of mouse chromosome 1 using an interspecific cross segregating for the gld autoimmunity mutation.

Authors:  M L Watson; P D'Eustachio; B A Mock; A D Steinberg; H C Morse; R J Oakey; T A Howard; J M Rochelle; M F Seldin
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

10.  Serine/threonine phosphorylation of the gamma-subunit after activation of the high-affinity Fc receptor for immunoglobulin G.

Authors:  D L Durden; H Rosen; J A Cooper
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.